IFNG and COVID-19: Treatment of mice with IFN-γ, in combination with TNF-α, induces a cytokine shock that mirrors the tissue damage of COVID-19, and neutralizing antibodies targeting these cytokines protect mice from mortality following SARS-CoV-2 infection [137].